Catalyst Wire Dossier Catalyst Wire Dossier

YM060

· Astellas Pharma Inc
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for YM060, covering 2011-07-13 to 2015-10-12. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Efficacy and Safety of YM060 in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS) [Phase 3]

See pricing